Charles M. Alexander, MD, FACP, FACE is an endocrinologist who has more than 35 years of experience in diabetes – in both direct care and research. Since 2016, he has provided advisory services to pharmaceutical and medical device companies. Dr. Alexander retired from Merck in 2015 after nearly 25 years in both Outcomes Research and Medical Affairs. Prior to joining Merck, he practiced diabetes, endocrinology and internal medicine in Los Angeles for ten years and was Clinical Professor of Medicine at the Keck School of Medicine of the University of Southern California (KSOM/USC). Dr. Alexander has been a member of Penn Medicine’s Institute for Diabetes, Obesity and Metabolism (IDOM) Leadership Council since 2016, and an advisor for the diaTribe Foundation since 2016. Dr. Alexander received his medical degree from KSOM/USC where he completed his postgraduate training in internal medicine and diabetes/endocrinology. Dr. Alexander is board-certified in Internal Medicine and Endocrinology-Metabolism and is a Fellow of both the American College of Physicians and the American College of Endocrinology. He is the author of numerous scientific articles and a frequent reviewer for medical journals.
Richard M. Bergenstal, MD, is an endocrinologist and executive director of the International Diabetes Center at HealthPartners, Minneapolis, MN. In 2010 he was the American Diabetes Association’s president, Medicine & Science, and ADA’s ‘Outstanding Physician Clinician’ in 2007. He was assistant professor at the University of Chicago, before joining the International Diabetes Center in 1983. He has worked to standardize CGM metrics and data display in the Ambulatory Glucose Profile (AGP) Report. Implementing CGM and automated insulin delivery systems in practice and integrating the data in the electronic health record has been a recent research and quality improvement focus.
Zachary Bloomgarden, MD is MD is a clinician in private practice, clinical professor at the Icahn School of Medicine at Mount Sinai, and editor of the Journal of Diabetes, master of the American College of Endocrinology, and author of nearly 600 articles on a variety of topics pertaining to diabetes.
Dr. Michael Dougan, MD, PhD is an internal medicine resident at Massachusetts General Hospital with a longstanding interest in science education. He received his MD and PhD from Harvard Medical School, where his research focused on immune modulation and chronic inflammation.
Dr. Steve Edelman, MD is a clinical professor of Medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego. He is the founder and director of Taking Control of Your Diabetes (TCOYD), a not-for-profit organization focused on educating and motivating people with diabetes since 1995. He was awarded the Diabetes Educator of the Year by the American Diabetes Association in 2009, the Distinction in Endocrinology award by the American Association of Clinical Endocrinologists in 2011, and awarded the Lifetime Achievement award by the Association Of Diabetes Care And Education Specialists (ADCES).
Satish K. Garg, MD is a Professor of Medicine and Pediatrics at the Young Adult Clinic at the Barbara Davis Center for Diabetes at the University of Colorado School of Medicine at the Anschutz Medical Campus, in Aurora, Colorado and the editor in chief of Diabetes Technology and Therapeutics Journal. He is a prolific researcher with over 325 original manuscripts in peer-review journals and is considered a leading expert in early detection of diabetes, evaluating new glucose sensors, closed-loop systems, and multiple diagnostic and therapeutic tools and therapies, including insulin analogs and alternate ways to deliver insulin and possible adjunctive therapies for T1D in particular.
Dr. James R. Gavin III, M.D., Ph.D is a clinical professor of Medicine at the Emory University School of Medicine and serves as the chief medical officer of Healing our Village, Inc. a health communication corporation that specializes in targeted advocacy, training, education, and outreach for health care professionals and minority communities. Additionally, he was the president of the Morehouse School of Medicine from 2002-2004, and is chairman emeritus of the Partnership for a HealthierAmerica (PHA). He has published more than 250 articles and abstracts in such publications as Science, Journal of Applied Physiology, Diabetes, and the American Journal of Physiology.
Dr. Barry J. Goldstein, MD, PhD, FACE is an Endocrinologist with over 30 years of diabetes experience in clinical and basic R&D in academia and industry. After 16 years as Division Chief at Jefferson Medical College, he became VP and TA Head for Diabetes & Endocrinology at Merck Research Laboratories for 5 years prior to assuming his current position at Labcorp Drug Development (formerly Covance) in 2013. Dr. Goldstein is an elected member of the ASCI and AAP, a past Associate Editor of Diabetes and the JCEM, and has served on grant and program review panels for NIH, ADA, JDRF, and industry.
Lutz Heinemann, PhD is a member of the German Diabetes Association (DDG) and the European Association for the Study of Diabetes (EASD). He also sits on the scientific advisory boards of various pharmaceutical and diagnostics companies. Since 2011, he has been the managing editor of the Journal of Diabetes Science and Technology. Professor Heinemann’s scientific research is focused on insulin pharmacology and diabetes technology. Between 2010 and 2015, he acted as coordinator for the EU-funded project [email protected]. In 2007 he received an award for “Leadership in Diabetes Technology” from the Diabetes Technology Society and, in 2012, was granted the “Artificial Pancreas Research Award” by the Diabetes Technology Society.
Dr. Irl Hirsch, MD, professor of medicine in the division of Metabolism, Endocrinology, and Nutrition at the University of Washington, has authored more than 250 research papers, written more than 60 editorials, three commentaries for The Journal of the American Medical Association, numerous book chapters, six books for patients and physicians, and is well known for his yearly “rants” in “Diabetes Technology and Therapeutics.” He is the former chair of the Professional Practice Committee for the American Diabetes Association and has served as editor-in-chief of two ADA journals, “Clinical Diabetes” and “DOC News”. He is an associate editor of Diabetes Technology and Therapeutics and has been on the editorial board of “Diabetes Care.”
Jeff Hitchcock is the President and Founder of Children with Diabetes, one of the largest diabetes-related web sites in the world. CWD offers education and support to families living with type 1 diabetes through its web site and its conferences. Of note is its national Friends for Life conference held each year. He is particularly inspired by his daughter Marissa, who has type 1 diabetes. In addition to his work at CWD, Jeff is involved in programs with the T1D Exchange, various advocacy groups, and is a sought-after speaker at national and international conferences on the impact of type 1 diabetes on families.
Philip Home, MA, DPhil, DM, FRCP trained in medicine at Oxford University and is currently Professor Emeritus of Diabetes Medicine at Newcastle University, UK. Dr. Home has published over 500 papers, books and reviews on aspects of diabetes. He was Editor of Diabetic Medicine and active on many medical editorial boards. Dr. Home has been chairman of global and national (UK) diabetes guideline groups, has advised extensively on new diabetes therapies, and has assisted in diabetes developments in countries on six continents. He lectures internationally on aspects of diabetes management.
Dr. David M. Kendall, MD is the Chief Scientific and Medical Officer of the American Diabetes Association. Prior to his appointment to the ADA, he was the Medical Director and Chief of Clinical and Professional Services at the International Diabetes Center in Minneapolis, MN. An active diabetes researcher, educator and clinician, Dr. Kendall has both clinical and laboratory based research interests. His clinical studies focus on the prevention and treatment of cardiovascular complications of diabetes while his laboratory research centers on emerging treatments for diabetes, insulin resistance, and the metabolic syndrome. He is particularly well known for his research on emerging incretin-based therapies for type 2 diabetes.
Dr. Boris Kovatchev, PhD is professor at the University of Virginia School of Medicine and School of Engineering, and founding director of the UVA Center for Diabetes Technology. Kovatchev has a 30-year track record in modeling, biosimulation, and algorithm development related to the treatment of diabetes. Currently, he is principal investigator of several projects dedicated to diabetes data science and the development of artificial pancreas systems. Kovatchev is author of over 200 peer-reviewed publications and holds 91 U.S. and international patents, among which are algorithms behind the Control-IQ closed-loop system (Tandem Diabetes Care). For his work, in 2020, he was elected a Fellow of the National Academy of Inventors.
Davida F. Kruger, MSN, APN-BC, BC-ADM who has been a certified nurse practitioner in diabetes for more than 40 years at Henry Ford Health System in Detroit, Michigan, where she is involved in both clinical practice and research. She has served as the editor in chief of Clinical Diabetes from 2011-2016 and an editor for Diabetes Spectrum from 2005-2008. A principal investigator on numerous diabetes care research projects, she is widely published, and has been honored by numerous national awards.
Dr. Anne Peters, MD is a clinical professor of medicine and diabetologist at the University of Southern California. She treats patients from all walks of life, with a particular focus on helping the underserved access technology. She has been a member of multiple guideline writing groups for individuals with both type 1 and type 2 diabetes, published over 200 papers and 4 books, given hundreds of talks and performed numerous clinical trials all with the hope of improving care for people living with diabetes.
William H. Polonsky, PhD, CDE is president and co-founder of the Behavioral Diabetes Institute, the world's first organization wholly dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also associate clinical professor in Medicine at the University of California, San Diego. Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as senior psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and chairman of the National Certification Board for Diabetes Educators. He received the American Diabetes Association’s 2020 Outstanding Educator in Diabetes Award and the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology.
Dr. Steven Jon Russell, MD, PhD is an associate professor of medicine at Harvard Medical School and the Massachusetts General Hospital. He completed MD/PhD training at UT Southwestern Medical Center at Dallas and Internal Medicine residency and Endocrinology fellowship at the MGH. His research has focused on development and testing of technologies to improve diabetes management. He was the principal clinical investigator of a collaboration with Boston University investigators to develop a wearable automated glucose control system, now licensed to Beta Bionics for commercialization as the iLet bionic pancreas. He is the study director for the ongoing iLet pivotal trials.
Jane Jeffrie Seley, DNP MPH MSN GNP BC-ADM CDCES CDTC FADCES, is assistant professor of medicine, nurse practitioner and diabetes care & education specialist in the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine. An advisor for the American Diabetes Association Technology Special Interest Leadership Group, she is also associate editor for ADA’s Diabetes Spectrum, section co-editor of Current Diabetes Reports and editor for the Journal of Diabetes Science & Technology and BMJ Open Diabetes Research & Care. An active clinician, researcher, speaker and author, she is committed to patient and professional education, innovative patient-centered diabetes management and advancing diabetes technology as a tool to assist people living with diabetes and the clinicians that care for them.
Jay Skyler, MD, MACP, FRCP is a professor of Medicine, Pediatrics, & Psychology, Division of Endocrinology Diabetes & Metabolism, Department of Medicine, University of Miami Leonard M. Miller School of Medicine. He is deputy director for Clinical Research and Academic Programs at the Diabetes Research Institute, University of Miami. For 22 years (1993-2015), he was study chairman for the NIH Diabetes Prevention Trial for T1D (DPT-1) and its successor T1D TrialNet, an international network conducting clinical trials to interdict type 1 diabetes. He was president of ADA and vice president of IDF. He was founding editor in chief of Diabetes Care.
Virginia Valentine, APRN-CNS, BC-ADM, CDCES, FADCES, practices as a diabetes specialist with Clinica La Esperanza in Albuquerque, NM, managing clinical challenges in diabetes in a primary care group. She is also a member of the hub team for Endo ECHO. Project ECHO is a collaborative model of medical education that empowers clinicians across New Mexico to provide better care to more people, right where they live. She received the “Outstanding Educator in Diabetes” Award in 2019 from American Diabetes Association and the APRN Excellence in Nursing NM award. She has been living well with type 2 diabetes for over 40 years.
Hope Warshaw, MMSc, RD, CDE, BC-ADM, is a diabetes nutrition consultant, freelance writer and book author, and owns a consulting practice, Hope Warshaw Associates, LLC, in Asheville, North Carolina. Ms. Warshaw has been involved in diabetes care and the diabetes community for over 40 years. She’s the author of several books published by ADA and has written consumer- and clinician-focused articles for many diabetes care magazines, journals and websites. As a volunteer, Ms. Warshaw served as the President of ADCES (formerly the American Association of Diabetes Educators) in 2016 and is currently the chair-elect of the Academy of Nutrition and Dietetics Foundation Board.
Gloria Yee, RN, CDE is a certified diabetes educator at the Diabetes Teaching Center at the University of California San Francisco. Her research focuses on diabetes technology. Gloria has type 1 diabetes.